Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus
Journal
Journal of Crohn's and Colitis
Journal Volume
15
Journal Issue
1
Pages
64-73
Date Issued
2021
Author(s)
Abstract
Aim: Our aim was to compare the risk of developing inflammatory bowel disease [IBD] between ever users and never users of metformin. Methods: Patients with newly diagnosed type 2 diabetes mellitus from 1999 to 2005 were enrolled from Taiwan's National Hea
Subjects
Crohn's disease; Inflammatory bowel disease; metformin; Taiwan; ulcerative colitis
SDGs
Other Subjects
acarbose; acetylsalicylic acid; angiotensin receptor antagonist; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; fibric acid derivative; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; meglitinide; metformin; oral ant
Publisher
Oxford University Press
Type
journal article